Renasant (NYSE:RNST) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings

Renasant (NYSE:RNST) reported Q2 CY2026 revenue of $273.9 million, up 1.6% year over year, which missed Wall Street estimates. Non-GAAP profit was $0.94 per share, 3.1% above analysts’ consensus. The article also cites tangible book value per share growth and notes the stock was flat at $43.92 after the report.

Original reporting
Published Jul 28, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 9:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Renasant (NYSE:RNST) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings — source image
Decision brief

The 30-second read

$RNSTBearishMed
01

Why it matters

A revenue miss and net interest income shortfall versus expectations can pressure estimates for future growth, even with EPS slightly above consensus.

02

Market read

Traders get a concrete earnings datapoint: Q2 revenue $273.9M (+1.6% YoY) missed estimates, while non-GAAP EPS $0.94 beat slightly.

03

What to watch

The article highlights TBVPS growth of about 3% annually and consensus TBVPS growth of 11.9% over the next 12 months, which could support a rebound thesis if net interest income stabilizes.

Relevance 6/10Novelty 6/10Timing: after-hours/after-reporting reaction for Q2 CY2026 results

Background

The piece frames Renasant’s revenue drivers (net interest income vs non-interest income) and discusses tangible book value as a key banking metric.

Company-level read

Ticker impact

$RNSTBearishMedium confidence
Context

Renasant reported Q2 CY2026 revenue of $273.9M, up 1.6% YoY, but below Wall Street estimates.

Expected impact

Likely continued pressure or choppy trading until management provides clearer drivers for net interest income and revenue acceleration.

Evidence & confidence

The article provides a concrete revenue miss versus estimates, notes net interest income missed, and states the stock was flat immediately after reporting, implying limited immediate repricing but persistent expectation risk.

Market effects

Reinforces that regional banks with slower revenue growth and net interest income softness may face tougher scrutiny from the market.

Limited to the Southeast-focused regional banking franchise narrative.

Low, as the disclosure is company-specific and not a macro or cross-sector shock.

Counterpoint

Non-GAAP EPS of $0.94 was 3.1% above consensus, suggesting profitability resilience even if top-line growth disappointed.

Key entities

  • Renasant

    Regional bank holding company reporting Q2 CY2026 results with revenue below analyst estimates.

Related articles

$RNSTMed

Renasant Q2 Earnings Call Highlights

Renasant (NYSE:RNST) management said it expects core margins to stay generally stable in the second half, citing loan maturities of about $1.25B over 12 months at ~4.95% and $50M to $60M monthly securities roll-offs into upper-4% to near-5% yields. The company is not adjusting its outlook for a Fed rate change. Q2 net interest income was $227.7M, non-interest income $51.2M, pre-provision net revenue $112.4M, and it recorded a $3.8M credit-loss provision.

$RNSTMed

RENASANT CORP (RNST): Results of Operations and Financial Condition

RENASANT CORP (RNST) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991_rnstx2q2026earn.htm EX-99.1 Document Contacts: For Media: For Financials: John S. Oxford James C. Mabry IV Senior Vice President Executive Vice President Chief Marketing Officer Chief Financial Officer (662) 680-1219 (662) 680-1281 RENASANT CORPORATION ANNOUN

$VIRCMed

VIRCO MFG CORPORATION (VIRC): Results of Operations and Financial Condition

VIRCO MFG CORPORATION (VIRC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Virco Reports Revenue through Six Months Declined 6.1% to $118.2 Million from $125.8 Million, as Rebalancing of School Furniture Market Continues • Operating Income of $10.5 Million for Second Quarter Remains Above Long-Term Average • Shipments Plus Backlog of $162.5

$NXMed

Quanex Building Products Q3 Earnings Call Highlights

Quanex Building Products (NX) reported Q3 results, with revenue declines in Hardware Solutions (-2.7%) and Extruded Solutions (+2.8%), while Custom Solutions grew (+8.5%). The company faced inflationary pressures but implemented price increases. Management expects Q4 revenue growth of 2-3% and EBITDA margin expansion. Quanex used cash flow for debt repayment and share repurchases, maintaining a cautious near-term outlook but positive long-term view on residential housing demand.